跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SPINRAZA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SPINRAZA
Authorized
STANDARD
SPINRAZA
Biogen Canada Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
27027de53be3b1dc
Company
Biogen Canada Inc
Type
Standard
Approval Details
Approval Id
27027de53be3b1dc
Drug Approval Canada Name
SPINRAZA
Product Name
SPINRAZA
Status
Marketed
Status Date
2017-08-29
Original Market Date
2017-08-29
Din
02465663
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intrathecal
Schedule
Prescription
Ahfs
92:18.00
Atc Original
M09AX07 NUSINERSEN
Atc Name
m 09 ax 07
Aig Number
0159230001
Company Name
Biogen Canada Inc
Company Address
3300 Bloor Street West, West Tower, Suite 1200, Toronto, Ontario, Canada, M8X 2X2
Active Ingredients
NUSINERSEN (NUSINERSEN SODIUM)
2.4 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
27027de53be3b1dc
Type
Standard
Back to Health Canada Approvals